On Monday, January 9, the next meeting of the Transparency Council.
Transparency Council, among others about drugs for cancer and diagnosis of tuberculosis
Published Jan. 3, 2023 09:58
Źródło: AOTMiT
The agenda includes:
Preparation of positions on drug evaluation:
• Libtayo (cemiplimab) as part of the drug program "Treatment of patients with advanced basal cell carcinoma of the skin with cemiplimab (ICD-10 C44)",
• Verzenios (abemaciclibum) as part of the drug program "Abemaciclib treatment of early HR+, HER2- breast cancer with high risk of recurrence".
Preparation of an opinion on the use of the M-TYPER medical device and M-TYPER reagents for the diagnosis of tuberculosis and other mycobacteriosis based on mass spectrometry technology.
Preparation of an opinion on the draft health policy program of the local government unit "Programme for early detection of hearing and vision defects in children living in the City of Opole for the years 2023-2026".
Source: AOTMiT
